Seagen | pharmaphorum

Thursday 3 April 2025

Channels

Content type

Categories

Categories

Sort by

Order

Seagen

News

Pfizer

FTC asks for more info on Pfizer’s $43bn Seagen takeover

The US Federal Trade Commission (FTC) has asked for more information on Pfizer’s $43 billion agreement to acquire Seagen before it will deliver a decision on whether the d

News

Seagen says Adcetris/Opdivo combo aces lymphoma trial

Seagen says Adcetris/Opdivo combo aces lymphoma trial

Seagen’s Adcetris was trounced by Bristol-Myers Squibb’s Opdivo in a head-to-head trial in classical Hodgkin lymphoma (cHL) reported at ASCO – but there may be a way for t

News

FDA clears Keytruda/Padcev regimen for bladder cancer

FDA clears Keytruda/Padcev regimen for bladder cancer

The combination of Merck & Co’s checkpoint inhibitor Keytruda and Seagen/Astellas’ antibody-drug conjugate Padcev has been approved by the FDA as an alternative to che

News

Former Seagen CEO Siegall pops up at new biotech

Former Seagen CEO Siegall pops up at new biotech

Siegall resigned from Seagen last year amid claims of domestic abuse, though was not charged.

News

Rumour of Pfizer, Seagen deal is true, with $43bn price tag

Rumour of Pfizer, Seagen deal is true, with $43bn price tag

Pfizer says Seagen's current and future drugs could add $10 billion to its revenues from 2030.

News

Forget Merck, now Pfizer is said to be after Seagen

Forget Merck, now Pfizer is said to be after Seagen

Rumour of negotiations comes as Pfizer is facing a steep patent cliff in the next few years.